Windlas Biotech Limited (WINDLAS.BO)
INR 924.95
(-0.21%)
INR 924.95
(-0.21%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 781.72 Million INR | 21.02% |
| 2022 | 701.91 Million INR | 12.19% |
| 2021 | 591.29 Million INR | 79.5% |
| 2020 | 361.68 Million INR | -9.45% |
| 2019 | 439.53 Million INR | -12.77% |
| 2018 | 923.11 Million INR | 1.98% |
| 2017 | 435.41 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 208.8 Million INR | -5.42% |
| 2023 Q2 | 219.27 Million INR | 10.93% |
| 2023 Q3 | 235.01 Million INR | 7.18% |
| 2023 FY | - INR | 21.02% |
| 2023 Q1 | 197.67 Million INR | 5.29% |
| 2023 Q4 | 220.05 Million INR | -6.37% |
| 2022 Q2 | 186.56 Million INR | 12.05% |
| 2022 FY | - INR | 12.19% |
| 2022 Q4 | 187.74 Million INR | 16.53% |
| 2022 Q3 | 161.11 Million INR | -13.64% |
| 2022 Q1 | 166.5 Million INR | -1.16% |
| 2021 Q4 | 168.46 Million INR | 13.56% |
| 2021 FY | - INR | 79.5% |
| 2021 Q3 | 148.35 Million INR | 3.21% |
| 2021 Q2 | 143.74 Million INR | 9.94% |
| 2021 Q1 | 130.74 Million INR | -4.12% |
| 2020 Q4 | 136.36 Million INR | -25.76% |
| 2020 Q3 | 183.68 Million INR | 41.78% |
| 2020 Q1 | 129.67 Million INR | 93.08% |
| 2020 Q2 | 129.55 Million INR | -0.09% |
| 2020 FY | - INR | -9.45% |
| 2019 FY | - INR | -12.77% |
| 2019 Q4 | 67.16 Million INR | 0.0% |
| 2018 FY | - INR | 1.98% |
| 2017 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 9.61 Billion INR | 91.871% |
| Aurobindo Pharma Limited | 61.78 Billion INR | 98.735% |
| Glenmark Life Sciences Limited | 6.86 Billion INR | 88.609% |
| Granules India Limited | 8.6 Billion INR | 90.914% |
| Indoco Remedies Limited | 2.64 Billion INR | 70.468% |
| Achyut Healthcare Limited | 524 Thousand INR | -149083.206% |
| Ajanta Pharma Limited | 12.56 Billion INR | 93.779% |
| Alkem Laboratories Limited | 24.19 Billion INR | 96.769% |
| Alpa Laboratories Limited | 86.12 Million INR | -807.636% |
| Brooks Laboratories Limited | 41.72 Million INR | -1773.37% |
| AstraZeneca Pharma India Limited | 2.35 Billion INR | 66.831% |
| Bajaj HealthCare Limited | 444.51 Million INR | -75.859% |
| Bliss GVS Pharma Limited | 1.47 Billion INR | 47.146% |
| Dr. Reddy's Laboratories Limited | 88.27 Billion INR | 99.114% |
| Eris Lifesciences Limited | 6.98 Billion INR | 88.811% |
| FDC Limited | 4.4 Billion INR | 82.24% |
| Glenmark Pharmaceuticals Limited | 11.34 Billion INR | 93.109% |
| Gufic Biosciences Limited | 1.48 Billion INR | 47.198% |
| Ind-Swift Laboratories Limited | 6.86 Billion INR | 88.607% |
| Ipca Laboratories Limited | 13.29 Billion INR | 94.122% |
| Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | -141.674% |
| Krebs Biochemicals & Industries Limited | -82.72 Million INR | 1044.939% |
| Lasa Supergenerics Limited | -65.08 Million INR | 1301.168% |
| Laurus Labs Limited | 8 Billion INR | 90.236% |
| Lupin Limited | 36.96 Billion INR | 97.885% |
| Mankind Pharma Limited | 28.09 Billion INR | 97.218% |
| Medicamen Biotech Limited | 245.66 Million INR | -218.212% |
| Medico Remedies Limited | 150.37 Million INR | -419.837% |
| Megasoft Limited | 284.73 Million INR | -174.547% |
| NATCO Pharma Limited | 18.79 Billion INR | 95.841% |
| Piramal Pharma Limited | 13.05 Billion INR | 94.012% |
| RPG Life Sciences Limited | 1.28 Billion INR | 39.0% |
| Sigachi Industries Limited | 883.39 Million INR | 11.51% |
| Sun Pharmaceutical Industries Limited | 138.36 Billion INR | 99.435% |
| Suven Pharmaceuticals Limited | 4.67 Billion INR | 83.287% |
| Syncom Formulations (India) Limited | 430.27 Million INR | -81.679% |
| Unichem Laboratories Limited | 742.35 Million INR | -5.303% |
| Wanbury Limited | 985.49 Million INR | 20.677% |
| ZIM Laboratories Limited | 462.09 Million INR | -69.168% |
| Zydus Lifesciences Limited | 56.22 Billion INR | 98.61% |
| Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 120.951% |
| Divi's Laboratories Limited | 25.43 Billion INR | 96.926% |
| Hester Biosciences Limited | 539.47 Million INR | -44.905% |
| Procter & Gamble Health Limited | 3.01 Billion INR | 74.067% |
| Amrutanjan Health Care Limited | 682.53 Million INR | -14.531% |
| Bal Pharma Limited | 345.59 Million INR | -126.197% |
| Strides Pharma Science Limited | 3.76 Billion INR | 79.235% |
| Venus Remedies Limited | 711.8 Million INR | -9.823% |
| Aarti Pharmalabs Limited | 3.9 Billion INR | 80.004% |
| Nectar Lifesciences Limited | 1.56 Billion INR | 50.011% |
| Shilpa Medicare Limited | 2.58 Billion INR | 69.794% |
| Aarti Drugs Limited | 3.24 Billion INR | 75.937% |
| IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | 70.01% |
| Suven Life Sciences Limited | -992.78 Million INR | 178.741% |
| Ind-Swift Limited | 1.06 Billion INR | 26.604% |
| Valiant Laboratories Limited | 12.73 Million INR | -6036.431% |
| J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | 91.626% |
| Solara Active Pharma Sciences Limited | -2.82 Billion INR | 127.702% |
| Themis Medicare Limited | 562.6 Million INR | -38.946% |
| Hikal Limited | 2.69 Billion INR | 70.964% |
| Torrent Pharmaceuticals Limited | 35 Billion INR | 97.767% |
| Sequent Scientific Limited | 549.8 Million INR | -42.183% |
| Novartis India Limited | 1.26 Billion INR | 38.413% |
| Wockhardt Limited | 1.08 Billion INR | 27.619% |
| Jubilant Pharmova Limited | 8 Billion INR | 90.236% |
| Biofil Chemicals and Pharmaceuticals Limited | 13.06 Million INR | -5884.688% |
| Neuland Laboratories Limited | 4.74 Billion INR | 83.536% |
| Morepen Laboratories Limited | 1.72 Billion INR | 54.708% |
| Kilitch Drugs (India) Limited | 287.42 Million INR | -171.974% |
| Mangalam Drugs & Organics Limited | 174.94 Million INR | -346.835% |